HUE036279T2 - Ropinirol készítmény - Google Patents

Ropinirol készítmény

Info

Publication number
HUE036279T2
HUE036279T2 HUE09777576A HUE09777576A HUE036279T2 HU E036279 T2 HUE036279 T2 HU E036279T2 HU E09777576 A HUE09777576 A HU E09777576A HU E09777576 A HUE09777576 A HU E09777576A HU E036279 T2 HUE036279 T2 HU E036279T2
Authority
HU
Hungary
Prior art keywords
ropinirole
composition
ropinirole composition
Prior art date
Application number
HUE09777576A
Other languages
English (en)
Inventor
Jernej Zadnik
Franc Vrecer
Original Assignee
Krka Tovarna Zdravil D D Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D Novo Mesto filed Critical Krka Tovarna Zdravil D D Novo Mesto
Publication of HUE036279T2 publication Critical patent/HUE036279T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HUE09777576A 2008-08-01 2009-07-31 Ropinirol készítmény HUE036279T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200800192A SI22849A (sl) 2008-08-01 2008-08-01 Ropinirolni pripravek

Publications (1)

Publication Number Publication Date
HUE036279T2 true HUE036279T2 (hu) 2018-06-28

Family

ID=41228271

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE09777576A HUE036279T2 (hu) 2008-08-01 2009-07-31 Ropinirol készítmény

Country Status (8)

Country Link
EP (1) EP2323634B1 (hu)
EA (1) EA023340B1 (hu)
ES (1) ES2659369T3 (hu)
HR (1) HRP20180222T1 (hu)
HU (1) HUE036279T2 (hu)
PL (1) PL2323634T3 (hu)
SI (2) SI22849A (hu)
WO (1) WO2010012482A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2452677A1 (en) * 2008-09-29 2012-05-16 Wockhardt Limited Extended release dosage form of ropinirole
ES2706880T3 (es) 2010-02-22 2019-04-01 Daiichi Sankyo Co Ltd Preparación sólida de liberación sostenida para uso oral
TW201132646A (en) * 2010-02-22 2011-10-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
GR1007629B (el) * 2011-07-13 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα ελεγχομενης αποδεσμευσης ενος μη εργολινικου αγωνιστη της ντοπαμινης
ES2706994T3 (es) 2012-09-03 2019-04-02 Daiichi Sankyo Co Ltd Composición farmacéutica de liberación prolongada de administración oral que contiene clorhidrato de hidromorfona
CN104473893A (zh) * 2014-11-21 2015-04-01 哈尔滨圣吉药业股份有限公司 一种盐酸罗匹尼罗缓释片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
GB0125088D0 (en) * 2001-10-18 2001-12-12 Smithkline Beecham Cork Ltd New use
GB0319874D0 (en) * 2003-08-22 2003-09-24 Glaxo Group Ltd Novel formulation
US20110287097A1 (en) * 2007-08-14 2011-11-24 Dr. Reddy's Laboratories, Inc. Pharmaceutical compositions comprising ropinirole

Also Published As

Publication number Publication date
SI2323634T1 (en) 2018-03-30
EA023340B1 (ru) 2016-05-31
SI22849A (sl) 2010-02-26
PL2323634T3 (pl) 2018-04-30
ES2659369T3 (es) 2018-03-15
EP2323634B1 (en) 2017-11-15
HRP20180222T1 (hr) 2018-03-09
WO2010012482A1 (en) 2010-02-04
EA201100287A1 (ru) 2011-08-30
EP2323634A1 (en) 2011-05-25

Similar Documents

Publication Publication Date Title
GB0815022D0 (en) Composition
GB0819633D0 (en) Composition
GB0822246D0 (en) Composition
GB0818473D0 (en) Composition
GB0801119D0 (en) Composition
GB0810554D0 (en) Herbicde composition
GB0809808D0 (en) Composition
GB0818472D0 (en) Composition
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
HRP20180222T1 (hr) Sastav ropinirola
PL2128199T3 (pl) Nowa kompozycja
EP2357204A4 (en) COMPOSITION
GB0810359D0 (en) Composition
GB0817656D0 (en) Composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
GB0818269D0 (en) Composition
GB0818231D0 (en) Composition
GB0813589D0 (en) Composition
GB0809983D0 (en) Composition
GB0903681D0 (en) Composition
GB0823344D0 (en) Composition
GB0821754D0 (en) Composition
GB0820259D0 (en) Composition